출판:Mind Commerce (마인드 코머스) 출판년월:2023년06월
Human Augmentation in Healthcare: Bionics, Organ and Body Part Replacement, Exoskeletons, and Robotics 2023 – 2028
헬스케어에서의 인간 증강 : 생체공학, 장기·신체 부위 이식, 외골격, 로보틱스 2023-2028년
페이지수 | 58 |
도표수 | 37 |
가격 | |
Single User License | USD 2,000 |
Multi User License(5명) | USD 2,500 |
Site License | USD 3,000 |
Enterprise License | USD 4,000 |
구성 | 영문조사보고서 |
Mind Commerce(マインドコマース)「헬스케어에서의 인간 증강 : 생체공학, 장기·신체 부위 이식, 외골격, 로보틱스 2023-2028년 – Human Augmentation in Healthcare: Bionics, Organ and Body Part Replacement, Exoskeletons, and Robotics 2023 – 2028」는 의료 분야에서 생체공학, 장기 이식, 외골격, 로보틱스 시장을 조사하고 기술 평가, 제품 및 서비스의 총괄, 응용 평가, 산업 임팩트 평가, 경쟁 분석 등을 제공합니다. 또한 본 보고서에서는 2023년부터 2028년까지의 의료용 인간 확장에 관한 다각적인 예측도 실시하고 있습니다.
주요 게시물
- 인트로덕션
- 생체공학 및 시장개발
- 의료용 생체공학 제품
- 의지 장비
- 인공장기
- 외골격형 파워드 슈트
- 의약품
- 군용
- 어시스트용
- 인간용 생체공학
- 기계와 전자 생체 공학 비교
- 인공 이식 및 웨어러블 생체공학 비교
- 3D 인쇄 및 생체공학
- 생체공학 및 인공지능
- 나노 기술 및 생체공학
- 생체 모방 사업
- 사이보그
- 생체공학 산업 환경
- 유스 케이스 및 예
- 인간 확장 시장 분석 및 수익 예측
- 기업 및 분석
- 정리 및 시장 전망
Overview
Human Augmentation represents mechanical and electronic additions to the human body to improve various body functions. In the healthcare sector, augmentation may include bionics, organ replacement, exoskeletons, and robotics to provide assistance to those that have physical impairments. The goals of augmentation are many and varied such as rehabilitation, elder care, work and lifestyle enablement.
In many cases, the goal is to replicate biological methods and systems found in nature via electrically or mechanically powered artificial devices. Examples range from artificial organ or body part replacement to exoskeleton suit or robotics. In the case of collaborative robots (Co-Bots), robotics is used in collaboration with a human being to enable functions that would otherwise be prohibitive due to physical limitations.
Bionics represents the application of biological methods and systems found in nature, leverage to support the healthcare industry via electrically and/or mechanically powered artificial devices. Devices include artificial organs, body parts, and exoskeleton, which either replaces damaged or weakened body parts. These devices act as the original functions very closely. The exoskeleton suit has also been used in other purposes like rehabilitation and elder care.
This human augmentation report addresses the market for bionics, organ replacement, exoskeletons, and robotics in the healthcare sector including technology assessment, product and service review, application evaluation, industry impact assessment, and competitive analysis. The report includes detailed forecasts covering many aspects of human augmentation in healthcare for 2023 through 2028.
Companies in Report:
- Abbott Laboratories
- AbbVie Inc.
- Abiomed
- Asahi Kasei Kuraray Medical Co. Ltd.
- Baxter International
- Bionic Power
- Boston Scientific Corporation
- Cochlear Ltd.
- Edwards Lifesciences Corporation
- Ekso Bionics Holdings Inc.
- ExoAtlet
- LivaNova PLC
- Lockheed Martin Corporation
- Medtronic plc
- Orthofix Holdings Inc.
- Ossur Corporate
- Otto Bock HealthCare GmBH
- RB3D
- Sarcos Corporation
- Sonova Holding AG
- Spring Active
- SRI International
- SynCardia Systems LLC
- Zimmer Biomet Holdings
목차
Table of Contents
Executive Summary
1.0 Introduction
1.1 Bionics Overview
1.2 Bionics Products and Application Industry
1.3 Bionics Growth Drivers
1.3.1 Healthcare Technology Advancement
1.3.2 Aging Population to Increase Organ Failure
1.3.3 Accident to Amputations
1.3.4 Exoskeleton Application
1.3.5 Substitute of Robotics
1.3.6 Government R&D Initiative
1.3.7 Increase of Income Especially in Emerging Economies
1.4 Bionics Market Limitations
1.4.1 High Cost of Device and Treatment
1.4.2 Government Regulations and Strict Approval process
1.4.3 Lack of Surgical Expertise
1.5 Bionics Impact on Society
1.5.1 Positive Impact
1.5.2 Negative Impact
2 Bionics Technology and Market Development
2.1 Medical Bionics Products
2.2 Orthotics and Prosthetics
2.3 Artificial Organ
2.4 Powered Exoskeleton
2.4.1 Medical Exoskeleton
2.4.2 Military Exoskeleton
2.4.3 Assistive Exoskeleton
2.5 Human Bionics
2.6 Mechanical vs. Electronics Bionics
2.7 Artificial Implants vs. Wearable Bionics
2.8 3D Printing and Bionics
2.9 Bionics and Artificial Intelligence
2.10 Nanotechnology and Bionics
2.11 Business Biomimetic
2.12 Cybernetic Organism
2.13 Bionics Industry Landscape
3 Use Cases and Examples
3.1 HELLEN – The Exoskeleton
3.2 Tracking and Predicting Epilepsy Seizures
3.3 Designing an Exoskeleton for Fitness
3.4 Robotic Exoskeleton Case Study
3.5 ReWalk Exoskeleton
3.6 Magnetic Encoders Allows the Building of ‘Life-Changing’ Exoskeletons
3.7 Indego Exoskeleton
4 Human Augmentation Market Analysis and Revenue Forecasts
4.1 Combined Bionics Revenue 2023 – 2028
4.2 Bionics Revenue by Industry Vertical 2023 – 2028
4.3 Medical Bionics Revenue 2023 – 2028
4.3.1 Medical Bionics Revenue by Product Category
4.3.2 Medical Bionics Revenue by Application Type
4.3.3 Implantable Medical Bionics Revenue by Product Type
4.3.4 Medical Bionics Revenue by Technology Type
4.3.5 Medical Mechanical Bionics Revenue by Product Type
4.3.6 Medical Bionics Revenue by End User Type
4.3.7 Medical Bionics Revenue by Region
4.3.8 North America Medical Bionics Revenue by Country
4.3.9 Europe Medical Bionics Revenue by Country
4.3.10 APAC Medical Bionics Revenue by Country
4.3.11 LAMEA Medical Bionics Revenue by Country
4.4 Defense Exoskeleton Bionics Revenue 2023 – 2028
4.4.1 Defense Exoskeleton Bionics Revenue by Product Category
4.4.2 Defense Exoskeleton Bionics Revenue by Technology Type
4.4.3 Defense Exoskeleton Bionics Revenue by Region
4.4.4 North America Defense Exoskeleton Bionics Revenue by Country
4.4.5 APAC Defense Exoskeleton Bionics Revenue by Country
4.4.6 Europe Defense Exoskeleton Bionics Revenue by Country
4.4.7 ROW Defense Exoskeleton Bionics Revenue by Country
5 Company and Analysis
5.1 Strategic Initiatives
5.2 Abbott Laboratories
5.3 AbbVie Inc.
5.4 Abiomed
5.5 Asahi Kasei Kuraray Medical Co. Ltd.
5.6 Baxter International
5.7 Zimmer Biomet Holdings
5.8 Boston Scientific Corporation
5.9 Cochlear Ltd.
5.10 Edwards Lifesciences Corporation
5.11 Ekso Bionics Holdings Inc.
5.12 LivaNova PLC
5.13 Medtronic plc
5.14 Orthofix Holdings Inc.
5.15 Otto Bock HealthCare GmBH
5.16 Sonova Holding AG
5.17 Ossur Corporate
5.18 SynCardia Systems LLC
5.19 Bionic Power
5.20 ExoAtlet
5.21 Lockheed Martin Corporation
5.22 RB3D
5.23 Sarcos Corporation
5.24 Spring Active
5.25 SRI International
6 Conclusions and Market Outlook
Figures
Figure 1: Bionics Product and Application Ecosystem
Figure 2: Bionics Industry Landscape
Figure 3: Global Bionics Market Revenue 2023 – 2028
Tables
Table 1: Global Bionics Revenue by Industry Vertical 2023 – 2028
Table 2: Global Medical Bionics Revenue by Product Category 2023 – 2028
Table 3: Global Orthopaedic Bionics Revenue by Product Type 2023 – 2028
Table 4: Global Bionics Limbs Revenue by Product Type 2023 – 2028
Table 5: Global Bionics Lower Limbs Revenue by Product Type 2023 – 2028
Table 6: Global Electrical Bone Growth Stimulators Revenue by Product Type 2023 – 2028
Table 7: Global Cardiac Bionics Revenue by Product Type 2023 – 2028
Table 8: Global Artificial Organs Revenue by Product Type 2023 – 2028
Table 9: Global Artificial Heart Valves Revenue by Product Type 2023 – 2028
Table 10: Global Bionics Pacemaker Revenue by Product Type 2023 – 2028
Table 11: Global Bionics Ventricular Assist Device (VADs) Revenue by Product Type 2023 – 2028
Table 12: Global Neural/Brain Bionics Revenue by Product Type 2023 – 2028
Table 13: Global Bionics Internal Neurostimulators Revenue by Product Type 2023 – 2028
Table 14: Global Bionics Ear Revenue by Product Type 2023 – 2028
Table 15: Global Medical Bionics Revenue by Application Type 2023 – 2028
Table 16: Global Implantable Medical Bionics Revenue by Product Type 2023 – 2028
Table 17: Global Externally Worn Medical Bionics Revenue by Product Type 2023 – 2028
Table 18: Global Medical Bionics Revenue by Technology Type 2023 – 2028
Table 19: Global Medical Mechanical Bionics Revenue by Product Type 2023 – 2028
Table 20: Global Medical Electronic Bionics Revenue by Product Type 2023 – 2028
Table 21: Global Medical Bionics Revenue by End User Type 2023 – 2028
Table 22: Medical Bionics Revenue by Region 2023 – 2028
Table 23: North America Medical Bionics Revenue by Country 2023 – 2028
Table 24: Europe Medical Bionics Revenue by Country 2023 – 2028
Table 25: APAC Medical Bionics Revenue by Country 2023 – 2028
Table 26: SEA Medical Bionics Revenue by Country 2023 – 2028
Table 27: LAMEA Medical Bionics Revenue by Country 2023 – 2028
Table 28: Global Defense Exoskeleton Bionics Revenue by Product Category 2023 – 2028
Table 29: Global Defense Exoskeleton Revenue by Technology Type 2023 – 2028
Table 30: Defense Exoskeleton Bionics Revenue by Region 2023 – 2028
Table 31: North America Defense Exoskeleton Bionics Revenue by Country 2023 – 2028
Table 32: APAC Defense Exoskeleton Bionics Revenue by Country 2023 – 2028
Table 33: Europe Defense Exoskeleton Bionics Revenue by Country 2023 – 2028
Table 34: ROW Defense Exoskeleton Bionics Revenue by Country 2023 – 2028